Specimen SS-COM-BTR-0972 // BITTER
Clear Brassica T4-PR-PH
Brassica oleracea var. sabellica
Kale
Target Trait
87.5
% reduction
Reported target: 87.5% bitter reduction
Technical Specifications
Genomic Edits
15
GC Content
(60%)
Construct Length
8,000 bp
Promoter System
Ubiquitin / T7
Expression System
Protoplast PEG-fusion
Host Strain
PEG-mediated
Pathway Edits
- TAS2R38 complete null
- Glucosinolate biosynthesis KO
- Myrosinase suppression
Key Interventions
Application Domains
Intended Use
Pharmaceutical excipient and nutraceutical formulation — bitterness-masked brassica extracts and active compounds for clinical and supplement applications
Access
Request Commercial Access
This construct is available exclusively to qualified institutions. Submit an inquiry to receive technical documentation and licensing terms.
Contact Us →No pricing is listed publicly. We respond to all qualified inquiries within 2 business days.